Generic vs Name Brand L-Thyroxine Products: Interchangeable or Still Not?

被引：16
|
作者：
Hennessey, James V. [1 ]
机构：
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2013年 / 98卷 / 02期
关键词：
HEALTHY-VOLUNTEERS; LEVOTHYROXINE; BIOEQUIVALENCE; DRUG;
D O I：
10.1210/jc.2012-4310
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：511 / 514
页数：4
相关论文
共 50 条
  • [41] Brand-Name vs. Generic Oral Bisphosphonate Medications: Prescribing Patterns and Variations over Eleven Years.
    Fraser, Lisa-Ann
    Albaum, Jordan
    Tadrous, Mina
    Burden, Andrea
    Shariff, Salimah
    Cadarette, Suzanne
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 : S193 - S193
  • [42] Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens
    Contin, Manuela
    Alberghini, Lucia
    Candela, Carmina
    Benini, Giulia
    Riva, Roberto
    [J]. EPILEPSY RESEARCH, 2016, 122 : 79 - 83
  • [43] Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D
    Dusetzina, Stacie B.
    Sarpatwari, Ameet
    Carrier, Michael A.
    Hansen, Richard A.
    Keating, Nancy L.
    Huskamp, Haiden A.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1605 - 1611
  • [44] Audiological evaluation (128-20.000 Hz) in women with autoinmune thyroiditis: The role of antibodies vs. l-thyroxine deficiency
    Montero, Oscar Luis Alvarez
    Valiente, Antonio Rodriguez
    Gil, Carmen Gorriz
    Berrocal, Jose Ramon Garcia
    [J]. ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2023, 74 (01): : 50 - 58
  • [45] Antibacterial effects of brand-name teicoplanin and generic products against clinical isolates of methicillin-resistant Staphylococcus aureus
    Fujimura, Shigeru
    Fuse, Katsuhiro
    Takane, Hidenari
    Nakano, Yoshihisa
    Gomi, Kazunori
    Kikuchi, Toshiaki
    Watanabe, Akira
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (01) : 30 - 33
  • [46] Nongenomic actions of L-thyroxine and 3,5,3′-triiodo-L-thyronine. Focus on "L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase"
    Bhargava, Maneesh
    Lei, Jianxun
    Ingbar, David H.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 296 (05): : C977 - C979
  • [47] Clinical and economic consequences in patients initiating therapy with clopidogrel brand-name vs. generic: A real-life retrospective study
    Sicras-Mainar, A.
    Escobar-Cervantes, C.
    Mico-Perez, R. M.
    Llisterri-Caro, J. L.
    [J]. MEDICINA DE FAMILIA-SEMERGEN, 2020, 46 (01): : 16 - 26
  • [48] L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
    Lin, Hung-Yun
    Sun, Mingzeng
    Tang, Heng-Yuan
    Lin, Cassie
    Luidens, Mary K.
    Mousa, Shaker A.
    Incerpi, Sandra
    Drusano, George L.
    Davis, Faith B.
    Davis, Paul J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 296 (05): : C980 - C991
  • [49] Treatment persistence with brand-name vs. generic metformin in monotherapy for type 2 diabetes: real-life retrospective study using the propensity matching score
    Sicras-Mainar, A.
    Sicras-Navarro, A.
    [J]. MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (05): : 321 - 331
  • [50] Comparative Effectiveness of Persistent Use of a Name-Brand Levothyroxine (Synthroid®) vs. Persistent Use of Generic Levothyroxine on TSH Goal Achievement: A Retrospective Study Among Patients with Hypothyroidism in a Managed Care Setting
    Liya Wang
    Yaozhu J. Chen
    Michael Grabner
    Bal Nepal
    Amit Bodhani
    Ramon Espaillat
    James V. Hennessey
    [J]. Advances in Therapy, 2022, 39 : 779 - 795
12345